Indivumed Therapeutics logo — Precision Oncology based on Excellent Data

Indivumed Therapeutics

Precision Oncology based on Excellent Data

Founded 2002 Germany Hamburg, Germany 93 employees

General Information

Company Name Indivumed Therapeutics
Founded Year 2002
Location Germany Hamburg, Germany +1
Employees 93
Social

Get notified when Indivumed Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Indivumed Therapeutics

Indivumed Therapeutics is a biotech company founded in 2002 with a focus on precision oncology. Their mission, "Precision Oncology based on Excellent Data," is underpinned by their unique approach to collecting tissue and data of unmatched quality and variety, which has enabled them to gain a deep understanding of the molecular reality of cancer. With over 20 years of innovation, the company remains committed to their vision of a world where precision oncology offers a cure for every cancer patient. Indivumed Therapeutics' ability to discover and validate novel therapeutic targets that would otherwise be undetectable sets them apart in the field of precision oncology. Though there is no information on their last investment or the involved investors at this time, their long-standing presence in the industry and their focus on leveraging data for precision oncology positions them as an intriguing prospect for potential venture capital interest. The company's headquarters in Germany serves as a strategic location within the biotech and precision medicine landscape. For further details about their mission and approach, interested parties can visit their website at www.indivumed-therapeutics.com, which also provides links to their imprint and privacy policy.

Taxonomy: Precision Oncology, Biotech, Tissue Collection, Data Quality, Therapeutic Targets, Precision Medicine, Cancer Research, Biobanking, Tumor Profiling, Target Identification, Multi-Omics, Drug Development, Biomathematics, Innovation

No funding data available for Indivumed Therapeutics yet.

Get notified when Indivumed Therapeutics raises funding

Indivumed Therapeutics Alternatives & Competitors

Indivumed Therapeutics vs

Define Quality in Oncology. AqVida - Your German Source for Premium Oncology Generics.

61 employees
Indivumed Therapeutics vs
Aevi
Aevi Germany

Innovating payments – empowering people 💚

Unknown
203 employees
B2B, Financial Services
Indivumed Therapeutics vs

Industrial metrology solutions & High-tech semiconductor equipment

141 employees
Industrial, Manufacturing

FAQ About Indivumed Therapeutics

Precision Oncology based on Excellent Data
Indivumed Therapeutics was founded in 2002.
Indivumed Therapeutics is headquartered in Hamburg, Germany.
Indivumed Therapeutics has approximately 93 employees.
Top alternatives and competitors to Indivumed Therapeutics include Aqvida GmbH, Aevi, ACCRETECH (Europe) GmbH, American Society of Clinical Oncology (ASCO), fodjan. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Indivumed Therapeutics and Aqvida GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Indivumed Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy